DR. LUIS BONAVITA, 1294, MONTEVIDEO, X3
Unaudited Consolidated Condensed Interim Financial Statements as of March 31, 2026 and For the Quarter ended March 31, 2026 and 2025
Announces Dismissal of New York State Securities Class Action
Earnings Presentation Q1'25
Completes Transition to a Majority Independent Board with Appointments of Paco Ybarra and Nelson Mattos
Announces Results of Annual General Meeting Held on December 10, 2025
Unaudited Consolidated Condensed Interim Financial Statements as of September 30, 2025 and for the nine-month and three-month periods ended September 30, 2025 and 2024
To Hold Annual General Meeting of Shareholders on December 10, 2025
Announces Closing of Secondary Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Annual and Transition Report of Foreign Private Issuers
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities of Certain Foreign Private Issuers
Direct Registration System
No filings found
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Schedule 13G - Ownership Report
Automatic Shelf Registration Statement for Securities of Certain Foreign Private Issuers and Certain Canadian Issuers, Offered on a Continuous Basis
Submission Upload
Correspondence